Thanks for taking my question. So just on the comment you made on the optimism around the US business, if you can take us through your thoughts as to how you see this business scale up from a slightly longer-term perspective, what are the kind of filings you would be chasing, any differentiated assets, if you have any big plans for injectables, biosimilars, etc. Since you would be staying put in this market, how should we think about the business evolving over the next five years?
Okay. Thank you.